ANDROGENS & anti-ANDROGENS Flashcards
TESTOSTERONE (1:1): (drug names)
- testosterone
- testosterone cypionate
- testosterone enanthate
testosterone DERIVATIVES: (drug names)
- fluoxymesterone (1:2)
- oxymetholone (1:3)
- oxandrolone (1:3-1:13)
- nandrolone decanoate (1:2.5-1:4)
androgens → pharmacokinetics:
- ineffective taken ORALLY → testosterone is given IM or as patches, gels, buccal tablets
- derivatives are alkylated on 17a position → allows oral administration, longer t1/2
androgens → indications:
- primary hypogonadism
- secondary hypogonadism (failure of hypothalamus or pituitary)
- chronic wasting (HIV, cancer)
- aging
- endometriosis
- anemia
- osteoporosis
- growth stimulation (delayed puberty)
- protein anabolic agent
- used by athletes & body builders to increase lean body mass, muscle strength & endurance
androgens → CONTRAindications:
- breast, prostate carcinoma
- pregnancy expectation
- avoid in infants & young children
- caution in renal & cardiac disease predisposed to edema
androgens → side effects in WOMEN:
- hirsutism, acne, baldness
- deep voice
- excessive muscle development
- depression
- endometrial bleeding
androgens → side effects in MEN:
- priapism
- impotence
- decreased spermatogenesis
- gynecomastia
- cosmetic change
- prostate growth
androgens → side effects in CHILDREN:
- abnormal sexual maturation
2. growth disturbances
androgens → other side effects:
- atherosclerosis
- sodium retention and edema
- hepatic dysfunction, cholestasis
- sleep apnea, aggression
- erythrocytosis
anti-ANDROGENS: (drug names)
- leuprolide
- finasteride
- dutasteride
- flutamide
- nilutamide
- enzalutamide
- bicalutamide
leuprolide → mechanism of action:
GnRH analog + AR antagonist
finasteride & dutasteride → mechanism of action:
inhibit 5a reductase → decreased DHT
flutamide + nilutamide + enzalutamide + bicalutamide → mechanism of action:
competitive inhibitors of androgens at target cell
finasteride & dutasteride → indications:
- BPH
- prostate cancer
- male baldness
flutamide + nilutamide + enzalutamide + bicalutamide → indications:
ORAL treatment for prostate cancer